Why is diversity important in clinical research and to Science 37? We sat down with our co-founder and chief medical officer, Dr. Belinda Tan, to find out.
The completion of Science 37’s first siteless clinical trial demonstrates that this kind of study can actually work, and it can work well for all involved.
Decoding clinical trial materials can be overwhelming, but a patient-centered approach can demystify the process and break down barriers to participation.
Participating in clinical research comes with risks and benefits. Jamie Holloway explores the many safeguards that protect clinical trial participants.